Drugs / UMSC-exo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04213248 | Feb 2020 → May 2023 | dry eye syndrome | Zhongshan Ophthalmic Center, Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UMSC-exo | “Participants will receive artificial tears for 2 weeks to get the normalized baseline, followed by UMSC-exo 10ug/drop, four times a day for 14 days.” NCT04213248 ↗ |
| Modality | Other / unclassified | “MSC-Exos, nano-sized extracellular vesicles” PMID 39839752 ↗ Jan 2025 |